Use of IgG₁immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal route

摘要

The present invention concerns the use of immunoglobulins of IgG1 type, and more generally of ligands of the CD32 receptor, for the treatment of inflammatory diseases and manifestations, in particular of allergies and auto-immune diseases, more particularly the treatment of allergic asthma, the immunoglobulins and ligands being administered via mucosal route, in particular via sublingual route.

主权项

1. A method of treatment of allergic asthma, and manifestations thereof, in a subject having allergic asthma to an allergen, comprising administering a therapeutically effective amount of immunoglobulin of IgG1 type to the subject, the immunoglobulin of IgG1 type being administered via the sublingual route.